Please login to the form below

imatinib

This page shows the latest imatinib news and features for those working in and with pharma, biotech and healthcare.

Gleevec/Glivec (imatinib).

NICE recommends Novartis’ Rydapt for advanced SM treatment

and imatinib.
WHO to test three more potential COVID-19 treatments

The drugs – artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised COVID-19 patients. ... Imatinib is the most convenient of the three and will be given
Novartis' asciminib tops Pfizer's Bosulif in chronic myeloid leukaemia trial

Although the treatment of CML was transformed by the arrival of first-line TKIs like Novartis’ own Gilvec (imatinib), there are limited options for patients whose disease has developed resistance to
FDA clears Blueprint’s $32k-per-month GI cancer drug

imatinib) and Pfizer’s Sutent (sunitinib), which are also available as generics, and Bayer’s Stivarga (regorafenib) which is still in patent.
Novartis gets speedy reviews for new Kymriah filings

as Glivec (imatinib) are succumbing to generic competition.

More from news
Approximately 5 fully matching, plus 82 partially matching documents found.

Cost containment and the German market

The main sales drivers are biopharmaceutical medicines like the monoclonal antibody adalimumab, TNF-alpha inhibitor etanercept as well as the oncologic drugs imatinib and enzalutamide.
Turkey's pharma market is ripe for profitability

Philipp Haas, chairman and CEO, explains: “We created the first generic for Imatinib available in the Turkish market.
Interview: Harvey Berger and Timothy Clackson, Ariad

recommended for use in patients who have grown resistance to Tasigna (nilotinib) and Gleevec/Glivec (imatinib mesylate) from Novartis and Bristol-Myers Squibb's Sprycel (dasatinib).

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Bayer’s Jörg Reinhardt to replace Daniel Vasella as Novartis chair

Novartis also launched key products, such as cancer treatment Gllevec/Glivec (imatinib) and blood pressure medicine Tekturna (aliskiren), during Dr Vasella's time in charge.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Why you should feel optimistic about the future of healthcare

Precision medicines already exist; imatinib works to treat leukaemia only when the cancer cells have a particular genetic makeup, Sotorasib targets a specific mutation in people with lung cancer to halt

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

No results were found

Add my company

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...

The importance of accelerating clinical trial diversity: Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications: There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day: At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....

Email:
Password: